Prevalence of Biofilm-forming and Carbapenemase-producing Gram-negative Bacilli Colonizing Indwelling Urinary Catheters of Patients
DOI:
https://doi.org/10.56919/usci.2542.027Keywords:
Gram-negative Bacilli (GNB), Biofilm forming, carbapenemase, Indwelling Urinary CathetersAbstract
The increasing prevalence of biofilm-forming and carbapenemase-producing Gram-negative Bacilli (GNB) in catheterized patients is linked to significant clinical challenges, including persistent infections, prolonged hospital stays, and higher colonization rates. To address these issues, establishing localized antimicrobial resistance (AMR) surveillance data is critical for guiding effective patient management and implementing robust infection prevention and control strategies. This study analyzed 200 indwelling urinary catheters (IUCs) from hospitalized patients using standard microbiological techniques, with isolates characterized using the VITEK 2 system. Phenotypic screening for biofilm production and carbapenem resistance was conducted using the Congo Red Assay and the Carba NP Test, respectively. Carbapenemase genes were identified via Polymerase Chain Reaction (PCR) with specific primers. Of the 200 samples, 164 (82.0%) were positive for GNB, with 87 (43.5%) identified as biofilm producers. Carbapenem resistance was confirmed in 89 (44.5%) isolates using CRE agar and the Carba NP Test. The distribution of carbapenemase genes among GNB isolates was as follows: blaKPC (29.5%), blaNDM (100%), blaVIM (13.5%), blaOXA (100%), and blaIMP (20.0%). Antibiogram analysis revealed high resistance rates (54.5%-100%) to amoxicillin-clavulanic acid, trimethoprim-sulfamethoxazole, ceftriaxone, meropenem, and ertapenem. However, susceptibility was observed to nitrofurantoin, ciprofloxacin, and Gentamicin, suggesting their potential as empiric treatments for GNB infections in catheterized patients. The study highlights the importance of adhering rigorously to structured catheter care protocols, including daily assessment of catheter necessity and strict adherence to aseptic techniques during insertion and maintenance. Regular training for healthcare staff on best practices for catheter management is essential to reduce colonization rates and improve clinical outcomes for patients at risk of carbapenem-resistant GNB (CR-GNB) infections. These findings highlight the urgent need for localized AMR surveillance and targeted infection control measures to mitigate the growing threat of multidrug-resistant GNB in healthcare settings.
References
Abouelfetouh, A., Torky, A. S., & Aboulmagd, E. (2019). Phenotypic and genotypic characterization of Carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrobial Resistance and Infection Control, 8, 1–9. https://doi.org/10.1186/s13756-019-0611-6
Amer, W. H., Khalil, H. S., & Abd ELWahab, M. A. A. (2016). Characterization of carpabenem resistant Enterobacteriaceae in risk factors, phenotypic and genotypic characterization of carbapenem resistant Enterobacteriaceae in Tanta University Hospitals, Egypt. International Journal of Infection Control, 12, 1–11. https://doi.org/10.3396/IJIC.v12i2.012.16
Amisu, M. A., Awobusuyi, J., Salako, B. L., Mutiu, W. B., & Ojongbede, M. (2019). Localization of urinary tract infection in catheterized adults patients: Experience with the bladder washout technique. Tropical Journal of Nephrology, 14(2), 113–120.
Anane, Y. A., Apalata, T., Vasaikar, S., Okuthe, G. E., & Songca, S. (2020). Molecular detection of carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii clinical isolates in South Africa. International Journal of Microbiology, 1, 10–23. https://doi.org/10.1155/2020/7380740
Asmare, Z., Awoke, T., Genet, C., Admas, A., Melese, A., & Mulu, W. (2024). Incidence of catheter-associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia. Antimicrobial Resistance and Infection Control, 13, 10–21. https://doi.org/10.1186/s13756-024-01368-7
Atrissi, J., Milan, A., Bressan, R., Lucafò, M., Petix, V., & Busetti, M. (2021). Interplay of Opdp porin and chromosomal carbapenemases in the determination of carbapenem resistance/susceptibility in Pseudomonas aeruginosa. Microbiology Spectrum, 9, e01186-21. https://doi.org/10.1128/Spectrum.01186-21
Awoke, N., Kassa, T., & Teshager, L. (2019). Magnitude of biofilm formation and antimicrobial resistance pattern of bacteria isolated from urinary catheterized inpatients of Jimma University Medical Center, Southwest Ethiopia. International Journal of Microbiology, 20, 19–21. https://doi.org/10.1155/2019/5729568
Barceló, I. M., Jordana-Lluch, E., Escobar-Salom, M., Torrens, G., Fraile-Ribot, P. A., Cabot, G., Mulet, X., Zamorano, L., Juan, C., & Oliver, A. (2022). Role of enzymatic activity in the biological cost associated with the production of AmpC β-lactamases in Pseudomonas aeruginosa. Microbiology Spectrum, 10, e02700-22. https://doi.org/10.1128/spectrum.02700-22
Bashir, M., Umar, A. B., & Bilyaminu, M. (2020). Determination of bacteria associated with urinary catheters from patients suffering from urinary tract infections. Dr. Sulaiman Al-Habib Medical Journal, 2(1), 20–23. https://doi.org/10.2991/dsahmj.k.200220.001
Bebell, L. M., Ngonzi, J., Bazira, J., Fajardo, Y., Boatin, A. A., & Siedner, M. J. (2017). Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PLOS ONE, 12(4), e0175456. https://doi.org/10.1371/journal.pone.0175456
Bouslah, Z. (2020). Carba NP test for the detection of carbapenemase-producing Pseudomonas aeruginosa. Médecine et Maladies Infectieuses, 50, 466–479. https://doi.org/10.1016/j.medmal.2019.12.002
Chetri, S., Bhowmik, D., Paul, D., Pandey, P., Chanda, D. D., Chakravarty, A., Bora, D., & Bhattacharjee, A. (2019). AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli. BMC Microbiology, 19, 210. https://doi.org/10.1186/s12866-019-1589-1
Clinical and Laboratory Standards Institute. (2021). Performance standards for antimicrobial susceptibility testing (31st ed.). CLSI.
Clinical and Laboratory Standards Institute. (2022). Performance standards for antimicrobial susceptibility testing (32nd ed.). CLSI Supplement M100.
Deshpande, P., Rodrigues, C., Shetty, A., Kapadia, F., Hedge, A., & Soman, R. (2010). New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: Treatment options with carbapenems compromised. Journal of Association of Physicians of India, 58, 147–149.
Drake, M. J., Clavica, F., Murphy, C., & Fader, M. J. (2024). Innovating indwelling catheter design to counteract urinary tract infection. European Urology Focus, 10, 713–719. https://doi.org/10.1016/j.euf.2024.09.015
Edemekong, C. I., Chukwujekwu, A. G., Okorie, M. E., Udenweze, E., Obodoechi, I. F., Ogbonna, I. P., & Livinus, N. P. (2025). Evaluation of antibacterial activity of selected medicinal plant on extended spectrum β-lactamase producing Salmonella enterica serovar Typhimurium. UMYU Scientifica, 4(1), 28–36. https://doi.org/10.56919/usci.2541.003
Elbadawi, H. S., Elhag, K. M., Mahgoub, E., Altayb, H. N., Ntoumi, F., Elton, L., McHugh, T. D., Tembo, J., Ippolito, G., Osman, A. Y., Zumla, A., & Abdel Hamid, M. M. (2021). Detection and characterization of carbapenem resistant Gram‐negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan. BMC Microbiology, 21, 136. https://doi.org/10.1186/s12866-021-02133-1
Flores-Mireles, A., Hreha, T. N., & Hunstad, D. (2019). Pathophysiology, treatment, and prevention of catheter-associated urinary tract infection. Topics in Spinal Cord Injury Rehabilitation, 25(3), 228–240. https://doi.org/10.1310/sci2503-228
Garza-González, E., Bocanegra-Ibarias, P., Bobadilla-Del-Valle, M., Ponce-de-León-Garduño, L. A., Esteban-Kenel, V., Silva-Sánchez, J., Garza-Ramos, U., Barrios-Camacho, H., López-Jácome, L. E., & Colin-Castro, C. A. (2021). Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the INVIFAR network. PLOS ONE, 16, e0248614. https://doi.org/10.1371/journal.pone.0248614
Garza-Ramos, U., Silva-Sánchez, J., López-Jácome, L. E., Hernández-Durán, M., Colín-Castro, C. A., Sánchez-Pérez, A., Rodríguez-Santiago, J., Morfín-Otero, R., Rodriguez-Noriega, E., & Velázquez-Acosta, M. D. (2023). Carbapenemase-encoding genes and colistin resistance in Gram-negative bacteria during the COVID-19 pandemic in Mexico: Results from the Invifar Network. Microbial Drug Resistance, 29, 239–248. https://doi.org/10.1089/mdr.2022.0226
Gashaw, M., Gudina, E. K., Ali, S., Gabriele, L., Seeholzer, T., Alemu, B., Froeschl, G., Kroidl, A., & Wieser, A. (2024). Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia. Frontiers in Microbiology, 15, 1336387. https://doi.org/10.3389/fmicb.2024.1336387
Gould, C. V., Umscheid, C. A., Rajender, Agarwal, K., Kuntz, G., & Pegues, D. A. (2019). Guideline for prevention of catheter-associated urinary tract infections. Centers for Disease Control and Prevention. https://www.cdc.gov/infectioncontrol/guidelines/cauti/
Health Protection Surveillance Centre (2011). Guidelines for the Prevention of Catheter-Associated Urinary Tract Infection. Published on behalf of SARI by HSE Health Protection Surveillance Centre, 2011. ISBN 978-0-9551236-9-6
Ilang, D. C., Peter, I. U., & Iroha, I. R. (2023a). Antibiotic resistance profile of clinical importance biofilm forming extended spectrum beta-lactamase and carbapenemase phenotype in Gram-negative bacteria isolates. International Journal of Pharmacognosy and Life Science, 4(2), 120–127. https://doi.org/10.33545/27072827.2023.v4.i2b.97
Ilang, D. C., Peter, I. U., & Iroha, I. R. (2023b). Characterization of VIM, VEB and CTX-M beta-lactamase gene in Escherichia coli and Pseudomonas aeruginosa isolated from urine samples of patients visiting a tertiary hospital in Abakaliki. International Journal of Medical Sciences and Pharma Research, 9(4), 7–11. https://doi.org/10.22270/ijmspr.v9i4.77
Jean, S. S., Harnod, D., & Hsueh, P. R. (2022). Global threat of carbapenem-resistant Gram-negative bacteria. Frontiers in Cellular and Infection Microbiology, 12, 823684. https://doi.org/10.3389/fcimb.2022.823684
John-Onwe, B. N., Aniokete, U. C., Ibiam, F. A., Peter, I. U., Iroha, C. S., & Iroha, I. R. (2023). Dissemination of multidrug-resistant, extensively drug resistant and pandrug-resistant Pseudomonas aeruginosa isolates among in-patients and out-patients in a multi-profile health care settings. Journal of Advances in Microbiology, 23(10), 109–115. https://doi.org/10.9734/jamb/2023/v23i10761
Joseph, I. S., Okolo, I. O., Udenweze, E. C., Nwankwo, C. E., Peter, I. U., Ogbonna, I. P., & Iroha, I. R. (2023). Comparison of antibiotic-resistant pattern of extended spectrum beta-lactamase and carbapenem resistant Escherichia coli isolates from clinical and non-clinical sources. Journal of Drug Delivery and Therapeutics, 13(7), 107–118. https://doi.org/10.22270/jddt.v13i7.5918
Karabay, O., Altindis, M., Koroglu, M., Karatuna, O., & Aydemir, Ö. A. (2016). The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey. Annals of Clinical Microbiology and Antimicrobials, 15, 1–6. https://doi.org/10.1186/s12941-016-0118-4
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023). Carbapenem-resistant Klebsiella pneumoniae: Virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics, 12, 234. https://doi.org/10.3390/antibiotics12020234
Kołpa, M., Wałaszek, M., Gniadek, A., Wolak, Z., & Dobroś, W. (2018). Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: A 10 year observation in a provincial hospital in Southern Poland. International Journal of Environmental Research and Public Health, 15(1), 112. https://doi.org/10.3390/ijerph15010112
Kulbay, A., Joelsson-Alm, E., Amilon, K., & Tammelin, A. (2024). Asymptomatic bacteriuria and urinary tract infection in geriatric inpatients after indwelling urinary catheter removal: A descriptive two-centre study. Infection Prevention in Practice, 6, 100411. https://doi.org/10.1016/j.infpip.2024.100411
Kumarasamy, K., Toleman, M., Walsh, T., & Al. E. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. The Lancet Infectious Diseases, 10, 597–602. https://doi.org/10.1016/S1473-3099(10)70143-2
Liofilchem. (2020). Chromogenic medium for the detection of carbapenem-resistant Enterobacteriaceae.
López-García, A., Rocha-Gracia, R. D. C., Bello-López, E., Juárez-Zelocualtecalt, C., Sáenz, Y., Castañeda-Lucio, M., López-Pliego, L., González-Vázquez, M. C., Torres, C., & Ayala-Nuñez, T. (2018). Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican hospital. Infection and Drug Resistance, 11, 1523–1536. https://doi.org/10.2147/IDR.S173455
Luu, T., & Albarillo, F. S. (2022). Asymptomatic bacteriuria: Prevalence, diagnosis, management, and current antimicrobial stewardship implementations. The American Journal of Medicine, 135, 236–244. https://doi.org/10.1016/j.amjmed.2022.03.015
Masi, M., Réfregiers, M., Pos, K. M., & Pagès, J. M. (2017). Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria. Nature Microbiology, 2, 17001. https://doi.org/10.1038/nmicrobiol.2017.1
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539
Musinguzi, B., Kabajulizi, I., Mpeirwe, M., Turugurwa, J., & Kabanda, T. (2019). Incidence and etiology of catheter-associated urinary tract infection among admitted patients at Kabale Regional Referral Hospital, South Western Uganda. Advances in Infectious Diseases, 9, 183–196. https://doi.org/10.4236/aid.2019.93014
Nakawuki, A. W., Nekaka, R., Ssenyonga, L. V. N., Masifa, G., Nuwasiima, D., & Nteziyaremye, J. (2022). Bacterial colonization, species diversity and antimicrobial susceptibility patterns of indwelling urinary catheters from postpartum mothers attending a tertiary hospital in Eastern Uganda. PLOS ONE, 17(1), e0262414. https://doi.org/10.1371/journal.pone.0262414
Nieto-Saucedo, J. R., López-Jacome, L. E., Franco-Cendejas, R., Colín-Castro, C. A., Hernández-Duran, M., Rivera-Garay, L. R., Zamarripa-Martinez, K. S., & Mosqueda-Gómez, J. L. (2023). Carbapenem-resistant Gram-negative bacilli characterization in a tertiary care center from El Bajio, Mexico. Antibiotics, 12, 1295. https://doi.org/10.3390/antibiotics12081295
Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S., & Stephen, S. (2012). Isolation and the biofilm formation of uropathogens in the patients with catheter-associated urinary tract infections (UTIs). Journal of Clinical and Diagnostic Research, 6(9), 1478–1482. https://doi.org/10.7860/JCDR/2012/4367.2537
Nomeh, L. O., Federica, O. I., Joseph, O. V., Moneth, E. C., Ogba, R. C., Nkechi, O. A., Peter, I. U., Akpu, P. O., Edemekong, C. I., & Iroha, I. R. (2023). Detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae implicated in urinary tract infection. Asian Journal of Research in Infectious Diseases, 2(1), 15–23. https://doi.org/10.9734/ajrid/2023/v12i1234
Nomeh, O. L., Chukwu, E. B., Ogba, R. C., Akpu, P. O., Peter, I. U., Nwuzo, A. C., & Iroha, I. R. (2022). Prevalence and antibiogram profile of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae among patients with urinary tract infection in Abakaliki, Nigeria. International Journal of Pathogen Research, 11(3), 14–28. https://doi.org/10.9734/ijpr/2022/v11i3212
Ogba, R. C., Nomeh, O. L., Edemekong, C. I., Nwuzo, A. C., Akpu, P. O., Peter, I. U., & Iroha, I. R. (2022). Molecular characterization of carbapenemase encoding genes in Pseudomonas aeruginosa from tertiary healthcare in South Eastern Nigeria. Asian Journal of Biology, Genetic and Molecular Biology, 12(4), 161–168. https://doi.org/10.9734/ajbgmb/2022/v12i4281
Okoche, D., Asiimwe, B. B., Katabazi, F. A., & Kato, L. (2015). Prevalence and characterization of carbapenem-resistant Enterobacteriaceae isolated from Mulago National Referral. PLOS ONE, 10(8), e0135745. https://doi.org/10.1371/journal.pone.0135745
Oumer, Y., Dadi, B. R., Seid, M., Biresaw, G., & Manilal, A. (2021). Catheter-associated urinary tract infection: Incidence, associated factors and drug resistance patterns of bacterial isolates in Southern Ethiopia. Infection and Drug Resistance, 14, 2883–2894. https://doi.org/10.2147/IDR.S311229
Patil, H. V., Patil, V. C., Patange, A. P., & Khan, M. A. (2024). Antibiotic resistance profiles of extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL)-producing Klebsiella pneumoniae isolates from diabetic foot ulcers: Implications for treatment strategies. Cureus, 16, e66089. https://doi.org/10.7759/cureus.66089
Perovic, O., Micro, F. S. A., Micro, M., Britz, E., Chb, M. B., & Chetty, V. (2016). In practice molecular detection of carbapenemase-producing genes in referral Enterobacteriaceae in South Africa: A short report. South African Medical Journal, 106(10), 975–977. https://doi.org/10.7196/SAMJ.2016.v106i10.11300
Peter, I. U., Okolo, I. O., Uzoeto, H. O., Edemekong, C. I., Thompson, M. D., Chukwu, E. B., Mohammed, I. D., Ubom, I. J., Joseph, O. V., Nwuzo, A. C., Akpu, P. O, and Iroha, I. R (2022). Identification and Antibiotic Resistance Profile of Biofilm-forming Methicillin-Resistant Staphylococcus aureus (MRSA) Causing Infection among Orthopedic Wound Patients. Asian Journal of Research in Medical and Pharmaceutical Science, 11(4): 45-55. https://doi.org/10.9734/ajrimps/2022/v11i4201
Philippon, A., Arlet, G., & Jacoby, G. A. (2002). Plasmid-determined AmpC-type beta-lactamases. Antimicrobial Agents and Chemotherapy, 46(1), 1–11. https://doi.org/10.1128/AAC.46.1.1-11.2002
Puro, V., Coppola, N., Frasca, A., Gentile, I., Luzzaro, F., & Peghetti, A. (2022). Pillars for prevention and control of healthcare-associated infections. Antimicrobial Resistance and Infection Control, 11(1), 1–13. https://doi.org/10.1186/s13756-022-01125-8
Reid, G., Charbonneau-Smith, R., Lam, D., Kang, Y. S., Lacerte, M., & Hayes, K. C. (1992). The bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia, 30(10), 711–717. https://doi.org/10.1038/sc.1992.138
Saleem, M., Moursi, S. A., Altamimi, T. N. A., Alharbi, M. S., Alaskar, A. M., Hammam, S. A. H., Rakha, E., Syed Muhammad, O. I., Almalaq, H. A., & Alshammari, M. N. (2025). Prevalence and molecular characterization of carbapenemase-producing multidrug-resistant bacteria in diabetic foot ulcer infections. Diagnostics, 15(2), 141. https://doi.org/10.3390/diagnostics15020141
Sewunet, T., Asrat, D., Woldeamanuel, Y., Aseffa, A., & Giske, C. G. (2022). Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter species from clinical samples at Jimma Medical Center, Ethiopia. Frontiers in Microbiology, 13, 951857. https://doi.org/10.3389/fmicb.2022.951857
Shahid, M., Saeed, N. K., Ahmad, N., Shadab, M., Joji, R. M., Al-Mahmeed, A., Bindayna, K. M., Tabbara, K. S., Ismaeel, A. Y., & Dar, F. K. (2023). Molecular screening of carbapenem-resistant K. pneumoniae (CRKP) clinical isolates for concomitant occurrence of beta-lactam genes (CTX-M, TEM, and SHV) in the Kingdom of Bahrain. Journal of Clinical Medicine, 12(24), 7522. https://doi.org/10.3390/jcm12247522
Sharif, F. B., Aminu, A., & Idris, A. M. (2020). Catheter associated urinary tract infection among patients attending some selected hospitals in Kano Metropolis. Bayero Journal of Medical Library Science, 5(2), 174–179.
Sonnevend, Á., Ghazawi, A., Hashmey, R., Jamal, W., Rotimi, V., & Shibl, A. (2015). Characterization of carbapenem-resistant Enterobacteriaceae with high rate of autochthonous transmission in the Arabian Peninsula. PLOS ONE, 10(7), e0131372. https://doi.org/10.1371/journal.pone.0131372
Stærk, K., Andersen, K., Hjelmager, J. S., Jensen, L. K., Jørgensen, B. M., Møller-Jensen, J., Lund, L., & Andersen, T. E. (2024). Effect of bladder catheterization on bacterial interference with asymptomatic Escherichia coli strain 83972 in an experimental porcine model of urinary tract infection. The Journal of Infectious Diseases, 229(4), 1–9. https://doi.org/10.1093/infdis/jiae404
Stickler, D. J. (2014). Clinical complications of urinary catheters caused by crystalline biofilms: Something needs to be done. Journal of Internal Medicine, 276(2), 120–129. https://doi.org/10.1111/joim.12220
Stickler, D. J. (2008). Bacterial biofilms in patients with indwelling urinary catheters. Nature Clinical Practice Urology, 5(11), 598–608. https://doi.org/10.1038/ncpuro1231
Suay-García, B., & Pérez-Gracia, M. T. (2019). Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics, 8(3), 122. https://doi.org/10.3390/antibiotics8030122
Tambyah, P. A., & Maki, D. G. (2000). Catheter-associated urinary tract infection is rarely symptomatic. Archives of Internal Medicine, 160(5), 678–682. https://doi.org/10.1001/archinte.160.5.678
Tolera, M., Abate, D., Dheresa, M., & Marami, D. (2018). Bacterial nosocomial infections and antimicrobial susceptibility pattern among patients admitted at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Advances in Medicine, 2018, 2127814. https://doi.org/10.1155/2018/2127814
Uduku, N. D., Chinwe, I. F., Happiness, O., Immaculate, N. M., Favor, N. O., Peter, I. U., Aniokete, U. C., & Iroha, I. R. (2023). Antibiotics susceptibility profile of biofilm-forming bacteria isolated from soybean milk drinks sold in Abakaliki metropolis, Nigeria. Advances in Research, 24(6), 168–176. https://doi.org/10.9734/air/2023/v24i6997
Wald, H. L. (2008). Indwelling urinary catheter use in the postoperative period. Archives of Surgery, 143(6), 551. https://doi.org/10.1001/archsurg.143.6.551
Warren, J. W. (2001). Catheter-associated urinary tract infections. International Journal of Antimicrobial Agents, 17(4), 299–303. https://doi.org/10.1016/S0924-8579(00)00359-9
Yuan, P. B., Dai, L. T., Zhang, Q. K., Zhong, Y. X., Liu, W. T., Yang, L., Chen, D. Q., & Ponraj, V. P. (2024). Global emergence of double and multi-carbapenemase producing organisms: Epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence. Microbiology Spectrum, 12(1), e00008-24. https://doi.org/10.1128/spectrum.00008-24
Yusuf, I., Arzai, A. H., Haruna, M., Sharif, A. A., & Getso, M. I. (2014). Detection of multidrug resistant bacteria in major hospitals in Kano. Brazilian Journal of Microbiology, 45(3), 791–798. https://doi.org/10.1590/S1517-83822014000300005
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
UMYU Scientifica recognizes the importance of protecting authors’ intellectual property while promoting the free exchange of scientific knowledge. The journal adopts a copyright-retention model that empowers authors to maintain ownership of their work while granting the journal rights necessary for publication and dissemination.
1. Copyright Ownership
Authors publishing with UMYU Scientifica retain full copyright and publishing rights to their work. By submitting a manuscript, authors agree to grant the journal a non-exclusive license to publish, reproduce, distribute, and archive the article in all forms and media for the purpose of scholarly communication.
2. Licensing Terms
All articles are published under the Creative Commons Attribution–NonCommercial (CC BY-NC) license.
This license permits others to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform, and build upon the material.
- For non-commercial purposes only, provided that proper credit is given to the original author(s) and UMYU Scientifica as the source, a link to the license is provided, and any modifications are clearly indicated.
Commercial reuse or distribution of the content requires written permission from both the author and the editorial office.
3. Author Rights
Authors are free to:
- Deposit all versions of their manuscript (preprint, accepted version, and published version) in institutional, disciplinary, or public repositories without embargo.
- Use and distribute their published article for non-commercial scholarly purposes, including teaching, conference presentations, and research sharing.
- Include their work in future books, theses, or compilations, provided proper citation to the journal is made.
4. Publisher’s Rights
Upon publication, UMYU Scientifica retains the right to:
- Host, index, and disseminate the article through the journal’s website and partner databases.
- Archive the content in long-term preservation systems such as the PKP Preservation Network (PKP-PN) and the Umaru Musa Yar’adua University Institutional Repository.
5. Attribution and Citation
Users must give appropriate credit to the author(s), include a link to the article’s DOI or the journal webpage, and indicate if changes were made. Proper citation is required whenever the work is reused or referenced.
6. License Reference
For detailed terms of use, please refer to the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0):
https://creativecommons.org/licenses/by-nc/4.0/









